KAI Kadant posts modest Q4 2025 EPS beat yet shares sink 248 amid absence of revenue details What would it take for Vaxcyte PCVX to double from here Smart Money Active 20260506 What is Eli Lilly LLY earnings growth rate Eye on Rally 20260501 DOMH Dominari shares rise 36 percent after Q1 2024 earnings release with limited public performance details VSEC Q1 2026 Earnings Strong EPS Beat of 278 Highlights Operational Execution Boston Omaha Corporation Q4 2025 Earnings Significant EPS Miss Triggers Stock Decline RCKY Q1 2026 Earnings EPS Misses Expectations as Revenue Details Remain Undisclosed LTC Properties Inc Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower STSS Q3 2025 Earnings Losses Widen Sharply as Revenue Remains Absent